Your browser is no longer supported. Please, upgrade your browser.
Settings
APYX Apyx Medical Corporation daily Stock Chart
APYX [NASD]
Apyx Medical Corporation
Index- P/E- EPS (ttm)-0.47 Insider Own0.10% Shs Outstand34.18M Perf Week11.36%
Market Cap170.20M Forward P/E- EPS next Y-0.63 Insider Trans487.91% Shs Float29.94M Perf Month8.46%
Income-16.00M PEG- EPS next Q-0.21 Inst Own53.80% Short Float2.02% Perf Quarter53.85%
Sales27.60M P/S6.17 EPS this Y-78.00% Inst Trans-0.42% Short Ratio4.58 Perf Half Y-33.77%
Book/sh2.06 P/B2.43 EPS next Y4.50% ROA- Target Price7.75 Perf Year-31.13%
Cash/sh- P/C- EPS next 5Y15.00% ROE- 52W Range2.81 - 8.59 Perf YTD-40.90%
Dividend- P/FCF- EPS past 5Y10.80% ROI-28.80% 52W High-41.79% Beta0.69
Dividend %- Quick Ratio6.40 Sales past 5Y0.40% Gross Margin67.10% 52W Low78.25% ATR0.31
Employees266 Current Ratio7.00 Sales Q/Q-10.70% Oper. Margin- RSI (14)48.85 Volatility5.45% 6.03%
OptionableYes Debt/Eq0.01 EPS Q/Q66.10% Profit Margin- Rel Volume0.35 Prev Close4.98
ShortableYes LT Debt/Eq0.01 EarningsAug 10 BMO Payout- Avg Volume131.77K Price5.00
Recom- SMA20-1.00% SMA50-0.33% SMA200-14.75% Volume46,601 Change0.40%
Apr-02-19Reiterated Dougherty & Company Buy $12 → $9
Aug-03-20 12:31PM  
Jul-30-20 09:54PM  
Jul-09-20 03:55PM  
Jul-02-20 08:48PM  
08:39AM  
Jun-25-20 05:49PM  
07:30AM  
Jun-23-20 11:15AM  
05:22AM  
Jun-22-20 04:05PM  
Jun-16-20 06:15AM  
Jun-06-20 09:00AM  
Jun-05-20 05:33PM  
May-29-20 03:45PM  
May-28-20 09:56AM  
May-27-20 01:02PM  
May-26-20 08:52AM  
May-23-20 08:00AM  
May-19-20 08:30AM  
May-18-20 08:00AM  
May-15-20 03:13PM  
May-12-20 04:31AM  
May-11-20 08:55AM  
08:10AM  
07:00AM  
May-04-20 07:10AM  
Apr-20-20 03:55PM  
08:00AM  
Apr-18-20 09:43AM  
Apr-17-20 10:50PM  
Apr-15-20 01:50PM  
Apr-12-20 03:30PM  
02:26PM  
02:26PM  
Apr-07-20 09:25AM  
Mar-31-20 02:15PM  
Mar-30-20 01:53PM  
Mar-28-20 02:20PM  
Mar-27-20 10:50PM  
Mar-26-20 01:10PM  
Mar-25-20 08:20PM  
07:47PM  
04:15PM  
03:22PM  
Mar-24-20 01:15PM  
12:13AM  
Mar-23-20 05:02PM  
01:20PM  
10:45AM  
Mar-20-20 01:00PM  
09:26AM  
Mar-19-20 04:50PM  
03:20PM  
02:24PM  
10:22AM  
Mar-18-20 09:24AM  
Mar-17-20 11:09PM  
07:15AM  
Mar-16-20 04:05PM  
04:04PM  
Mar-13-20 10:50PM  
Feb-05-20 04:05PM  
Jan-13-20 07:00AM  
Jan-06-20 12:00PM  
Dec-16-19 07:18AM  
Dec-03-19 07:00AM  
Nov-21-19 09:05AM  
Nov-15-19 08:38AM  
Nov-14-19 09:00AM  
Nov-12-19 07:20AM  
Nov-11-19 05:35PM  
05:02PM  
Nov-04-19 10:30AM  
07:30AM  
Oct-24-19 10:45AM  
Oct-14-19 07:30AM  
07:00AM  
Oct-11-19 09:00AM  
Sep-24-19 07:30AM  
Sep-18-19 08:49PM  
Sep-09-19 02:44PM  
Sep-03-19 05:13PM  
Aug-22-19 07:30AM  
Aug-08-19 11:24AM  
Aug-07-19 07:55PM  
04:05PM  
Aug-06-19 07:30AM  
Aug-05-19 07:30AM  
Jul-31-19 10:36AM  
08:48AM  
Jul-26-19 02:30PM  
Jul-15-19 07:30AM  
Jul-02-19 07:30AM  
Jul-01-19 07:30AM  
Jun-25-19 08:53PM  
Jun-17-19 01:57PM  
09:10AM  
Jun-16-19 07:18PM  
01:30PM  
Jun-14-19 12:30PM  
Apyx Medical Corporation, a energy technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue. It markets and sells Helium Plasma Technology under the Renuvion brand name in the cosmetic surgery market and under the J-Plasma brand name in the hospital surgical market. The company's Renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue; and the J-Plasma system allows surgeons to operate in eliminating unintended tissue trauma. It also designs, develops, manufactures, and sells electrosurgical and OEM generators and related accessories for medical device manufacturers. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Goodwin Charles D. IIChief Executive OfficerMay 13Buy3.3028,25093,19728,250May 14 01:27 PM